BMGL — Basel Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $17.34m
- $12.40m
- SG$11.32m
Annual cashflow statement for Basel Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 2.39 | 2.13 | 2.4 | -12.5 |
| Depreciation | ||||
| Non-Cash Items | 0.1 | 0.149 | 0.171 | 11.1 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.27 | -0.238 | -0.595 | -4.1 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Accounts Payable | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 2.79 | 2.6 | 2.51 | -4.34 |
| Capital Expenditures | -0.088 | -0.006 | -0.008 | -0.055 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | — | -11 |
| Acquisition of Business | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | -0.088 | -0.006 | -0.008 | -11 |
| Financing Cash Flow Items | -0.765 | -0.599 | 1.16 | 1.78 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -12.9 | -2.94 | -1.77 | 16.9 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -10.2 | -0.346 | 0.734 | 1.03 |